Financial reports
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
3 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
4 May 21
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
Current reports
8-K
Completion of Acquisition or Disposition of Assets
6 Mar 23
8-K
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
19 Jan 23
8-K
Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results
7 Nov 22
8-K
Other Events
22 Aug 22
8-K
Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 22
8-K
Concert Pharmaceuticals Announces Pricing of Public Offering
3 Jun 22
8-K
Regulation FD Disclosure
23 May 22
8-K
Other Events
12 May 22
8-K
Concert Pharmaceuticals Reports First Quarter 2022 Financial Results
5 May 22
Registration and prospectus
15-12G
Securities registration termination
16 Mar 23
25-NSE
Exchange delisting
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Mar 23
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
PRE 14A
Preliminary proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
28 Apr 20
DEF 14A
Definitive proxy
29 Apr 19
DEF 14A
Definitive proxy
3 May 18
DEFA14A
Additional proxy soliciting materials
22 May 17
Other
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
14 Mar 23
EFFECT
Notice of effectiveness
29 Apr 22
CORRESP
Correspondence with SEC
26 Apr 22
UPLOAD
Letter from SEC
8 Mar 22
EFFECT
Notice of effectiveness
17 Nov 20
CORRESP
Correspondence with SEC
12 Nov 20
UPLOAD
Letter from SEC
12 Nov 20